Subscribe

Pediatrix Medical Group, Inc. (MD)

USD26.14 -0.13 (-0.49%)
US NYSE Healthcare Medical - Care Facilities
Address 1301 Concord Terrace 33323
Sunrise, FL, US
CEO Mark S. Ordan
Website mednax.com
IPO 1995-09-20
CIK 893949 ISIN US58502B1061

Explore sections of this company profile

Description

Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix provides comprehensive maternal-fetal medicine services in both clinical and inpatient settings, involving specialists such as maternal-fetal medicine physicians, obstetricians, and genetic counselors. Furthermore, the group delivers pediatric cardiology services, addressing both congenital and acquired heart conditions in patients ranging from the fetal stage through adulthood, under the care of dedicated pediatric cardiologists. Beyond these core areas, Pediatrix extends its expertise to various other pediatric subspecialties, including those requiring intensivists, surgeons, and ophthalmologists, and supplies vital support to hospital departments like emergency rooms and labor and delivery units. Established in 1979 in Sunrise, Florida, and formerly known as MEDNAX, Inc. until its renaming in July 2022, the company managed a network of approximately 2,700 physicians as of February 2022.

Market Cap & Enterprise Value
Merger & Acquisition History
Target company Date Filing
Magella 2001-03-16 View
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD26.14 -0.13 (-0.49%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
793.3K
Beta
0.70
Float Shares
81.56M
Free Float %
98.2%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-0.60% +5.41% +8.95% +10.92% +3.00% +9.26% +62.74% +68.74% -23.90% -65.98% +337.33%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (33 ratings, all time) Hold
Price Targets & DCF
Current price
26.14
Low 19.00 -27.3%
Consensus 22.60 -13.5%
Median 22.00 -15.8%
High 27.00 +3.3%
DCF (Unlevered) 27.39 +4.8%
DCF (Levered) 42.13 +61.2%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 29% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 2 0
Hold 5 0
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month 1
27.00
+3.3%
Last Quarter 4
22.25
-14.9%
Last Year 7
21.86
-16.4%
All Time 16
20.63
-21.1%
Quality scores
Altman Z-Score
2.36
Grey zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
3 / 10
No MOAT
Composite Rating
A
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
4 / 5
High
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Care Facilities: +10.2%
    -4.9% Q1'26: +3.9% (vs Q1'25)
  • EPS growth Medical - Care Facilities: +19.2%
    +263.0% Q1'26: +50.0% (vs Q1'25)
  • FCF margin FCF growth · Medical - Care Facilities: +32.0%
    +11.0% Q1'26: -28.5% (vs Q1'25)
  • EBIT margin Medical - Care Facilities: +11.3%
    +13.2% Q1'26: +9.9% (vs Q1'25)
  • ROIC Medical - Care Facilities: +6.8%
    +18.8% Q1'26: +12.2% (vs Q1'25)
  • Share dilution Medical - Care Facilities: +0.0%
    +2.3% Q1'26: -3.2% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    2.41× Q1'26: 2.96× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.71) × ERP
WACC = 73% × Ke + 27% × Kd (5.5%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 27.14 Current price: 26.14
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2010
actual
Dec 2011
actual
Dec 2012
actual
Dec 2013
actual
Dec 2014
actual
Dec 2015
actual
Dec 2016
actual
Dec 2017
actual
Dec 2018
actual
Dec 2019
actual
Dec 2020
actual
Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
5 Rev. Ana.
5 EPS Ana.
Dec 2027
5 Rev. Ana.
5 EPS Ana.
Dec 2028
3 Rev. Ana.
3 EPS Ana.
Dec 2029
2 Rev. Ana.
1 EPS Ana.
Revenue
1.40B
est: 1.39B (+0.5%)
1.59B
est: 1.56B (+1.9%)
1.82B
est: 1.79B (+1.5%)
2.15B
est: 2.10B (+2.5%)
2.44B
est: 2.40B (+1.5%)
2.78B
est: 2.79B (-0.2%)
3.18B
est: 3.19B (-0.4%)
3.46B
est: 3.43B (+0.8%)
3.65B
est: 3.62B (+0.6%)
1.78B
est: 3.51B (-49.3%)
1.73B
est: 2.08B (-16.5%)
1.91B
est: 1.90B (+0.8%)
1.97B
est: 1.96B (+0.6%)
1.99B
est: 2.00B (-0.4%)
2.01B
est: 2.00B (+0.8%)
1.91B
est: 1.90B (+0.5%)
1.94B
1.93B – 1.95B
+1.7% YoY
1.98B
1.95B – 2.00B
+2.4% YoY
2.07B
2.07B – 2.07B
+4.2% YoY
2.22B
2.19B – 2.24B
+7.3% YoY
EBITDA
336.30M
est: 334.58M (+0.5%)
382.18M
est: 375.13M (+1.9%)
422.23M
est: 414.98M (+1.7%)
492.10M
est: 481.08M (+2.3%)
558.99M
est: 554.55M (+0.8%)
622.10M
est: 576.05M (+8.0%)
660.95M
est: 679.38M (-2.7%)
587.86M
est: 593.27M (-0.9%)
527.69M
est: 564.06M (-6.4%)
203.64M
est: -1.41B (+114.5%)
146.07M
est: -892.02M (+116.4%)
236.10M
est: 213.99M (+10.3%)
156.70M
est: 193.46M (-19.0%)
29.89M
est: 139.04M (-78.5%)
-28.37M
est: 138.64M (-120.5%)
274.22M
est: 132.26M (+107.3%)
134.55M
133.86M – 135.25M
+1.7% YoY
137.79M
135.72M – 139.16M
+2.4% YoY
143.60M
143.60M – 143.60M
+4.2% YoY
154.09M
152.39M – 155.49M
+7.3% YoY
EBIT
314.35M
est: 311.30M (+1.0%)
356.88M
est: 348.86M (+2.3%)
391.42M
est: 382.79M (+2.3%)
452.13M
est: 440.48M (+2.6%)
513.00M
est: 504.79M (+1.6%)
557.87M
est: 511.92M (+9.0%)
571.69M
est: 582.74M (-1.9%)
460.23M
est: 484.25M (-5.0%)
443.85M
est: 442.07M (+0.4%)
177.71M
est: -1.13B (+115.7%)
117.63M
est: 129.66M (-9.3%)
203.95M
est: 168.02M (+21.4%)
121.07M
est: 198.52M (-39.0%)
-6.28M
est: 106.82M (-105.9%)
-60.60M
est: 106.52M (-156.9%)
252.40M
est: 101.62M (+148.4%)
103.38M
102.84M – 103.91M
+1.7% YoY
105.86M
104.27M – 106.92M
+2.4% YoY
110.33M
110.33M – 110.33M
+4.2% YoY
118.39M
117.08M – 119.46M
+7.3% YoY
Net Income
202.69M
est: 201.72M (+0.5%)
218.00M
est: 214.00M (+1.9%)
240.91M
est: 236.75M (+1.8%)
280.52M
est: 273.23M (+2.7%)
317.28M
est: 312.17M (+1.6%)
336.32M
est: 308.79M (+8.9%)
324.91M
est: 331.20M (-1.9%)
320.37M
est: 319.10M (+0.4%)
268.63M
est: 266.36M (+0.9%)
-1.50B
est: -1.51B (+1.1%)
-796.49M
est: -1.09B (+27.1%)
130.96M
est: 107.65M (+21.7%)
66.34M
est: 82.66M (-19.8%)
-60.41M
est: -259.32M (+76.7%)
-99.07M
est: 109.92M (-190.1%)
165.39M
est: 174.22M (-5.1%)
197.47M
192.13M – 202.81M
+13.3% YoY
202.51M
191.08M – 213.94M
+2.5% YoY
193.46M
179.42M – 207.51M
-4.5% YoY
174.80M
172.29M – 176.87M
-9.6% YoY
SGA
154.27M
est: 153.50M (+0.5%)
170.36M
est: 167.04M (+2.0%)
193.54M
est: 190.56M (+1.6%)
218.21M
est: 212.72M (+2.6%)
247.53M
est: 243.67M (+1.6%)
305.92M
est: 280.59M (+9.0%)
372.57M
est: 379.55M (-1.8%)
417.11M
est: 421.84M (-1.1%)
432.38M
est: 428.24M (+1.0%)
244.51M
est: 407.23M (-40.0%)
248.95M
est: 384.74M (-35.3%)
263.36M
est: 218.72M (+20.4%)
231.40M
est: 227.32M (+1.8%)
227.54M
est: 245.69M (-7.4%)
238.44M
est: 244.99M (-2.7%)
240.79M
est: 233.72M (+3.0%)
237.77M
236.54M – 239.00M
+1.7% YoY
243.48M
239.83M – 245.92M
+2.4% YoY
253.75M
253.75M – 253.76M
+4.2% YoY
272.29M
269.28M – 274.77M
+7.3% YoY
EPS
2.17
est: 2.00 (+8.5%)
2.23
est: 2.16 (+3.2%)
2.41
est: 2.34 (+3.0%)
2.77
est: 2.64 (+4.9%)
3.30
est: 3.07 (+7.5%)
3.59
est: 4.06 (-11.6%)
3.47
est: 4.05 (-14.3%)
3.42
est: 3.30 (+3.5%)
2.95
est: 3.80 (-22.4%)
-17.78
est: 3.37 (-627.7%)
-9.31
est: 1.23 (-858.9%)
1.52
est: 1.53 (-0.8%)
0.80
est: 1.69 (-52.7%)
-0.72
est: -3.04 (+76.4%)
-1.19
est: 1.35 (-188.2%)
1.94
est: 2.08 (-6.9%)
2.28
2.25 – 2.38
+9.6% YoY
2.37
2.24 – 2.51
+3.7% YoY
2.30
2.10 – 2.43
-2.8% YoY
2.05
2.02 – 2.07
-11.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-11 A- 4/5 4/5 5/5 5/5 1/5 3/5 3/5
2026-05-08 A 4/5 5/5 5/5 5/5 1/5 3/5 3/5
2026-05-07 A 4/5 5/5 5/5 5/5 1/5 3/5 3/5
2026-05-06 A 4/5 5/5 5/5 5/5 1/5 3/5 3/5
2026-05-05 A 4/5 5/5 5/5 5/5 1/5 4/5 3/5
2026-05-04 A 4/5 4/5 5/5 5/5 1/5 4/5 3/5
2026-05-01 A 4/5 4/5 5/5 5/5 1/5 4/5 3/5
2026-04-30 A 4/5 4/5 5/5 5/5 1/5 4/5 3/5
2026-04-29 A 4/5 4/5 5/5 5/5 1/5 4/5 3/5
2026-04-28 A 4/5 4/5 5/5 5/5 1/5 4/5 3/5
2026-04-27 A 4/5 4/5 5/5 5/5 1/5 4/5 3/5
2026-04-24 A- 4/5 4/5 5/5 5/5 1/5 3/5 3/5
2026-04-23 A- 4/5 4/5 5/5 5/5 1/5 3/5 3/5
2026-04-22 A- 4/5 4/5 5/5 5/5 1/5 3/5 3/5
2026-04-21 A- 4/5 4/5 5/5 5/5 1/5 3/5 3/5
2026-04-20 A 4/5 5/5 5/5 5/5 1/5 3/5 3/5
2026-04-17 A 4/5 5/5 5/5 5/5 1/5 3/5 3/5
2026-04-16 A 4/5 5/5 5/5 5/5 1/5 3/5 3/5
2026-04-15 A 4/5 5/5 5/5 5/5 1/5 3/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
234.88M
OE per share TTM
2.69
Owner's Yield
13.57%
Maintenance CapEx ratio
17.34%
Maint CapEx / Avg PPE
6.3%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
66
Total invested
104.73M
Insider transactions (90d)
0
Beneficial owners (>5%)
29
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 (1) BlackRock, Inc. 13.13M 15.20% 12.95M 13.13M HC Delaware 2022-01-27
2 52-0556948 8.80M 9.80% 2.95M 8.80M IA Maryland 2019-02-14
3 David Rosen 8.28M 9.64% 8.28M IN State of Delaware 2024-11-13
4 LP 8.28M 9.64% 8.28M IA, PN State of Delaware 2024-11-13
5 13-4064930 7.36M 8.50% 6.27M 7.36M IA Delaware 2022-02-14
6 Lazard Asset Management LLC 6.99M 11.00% 5.03M 6.99M IA Delaware 2023-03-09
7 JEFFREY C. SMITH 5.92M 6.90% 5.92M IN 2021-08-31
8 PETER A. FELD 5.92M 6.90% 5.92M IN 2021-08-31
9 STARBOARD PRINCIPAL CO GP LLC 5.92M 6.90% 5.92M OO 2021-08-31
10 STARBOARD PRINCIPAL CO LP 5.92M 6.90% 5.92M PN 2021-08-31
11 STARBOARD VALUE GP LLC 5.92M 6.90% 5.92M OO 2021-08-31
12 STARBOARD VALUE LP 5.92M 6.90% 5.92M PN 2021-08-31
13 Abigail P. Johnson 5.56M 6.43% 5.56M IN 2022-02-09
14 FMR LLC 5.56M 6.43% 2.31M 5.56M HC 2022-02-09
15 (. 5.01M 5.94% 4.89M 5.01M IA Delaware Limited Partnership 2020-02-12
16 Edward C. Johnson 3d 4.19M 8.57% 4.19M IN Delaware 2012-02-14
17 30-0447847 4.11M 4.80% 4.00M 4.11M IA 2021-02-12
18 STARBOARD VALUE AND OPPORTUNITY MASTER FUND LTD 3.24M 3.80% 3.24M CO 2021-08-31
19 ArrowMark Colorado Holdings, LLC 2.68M 3.10% 2.68M 2.68M IA 2022-02-14
20 Elliott International Capital Advisors Inc. 1.29M 1.40% 1.29M 10.00 CO Delaware 2017-11-16
21 Elliott International, L.P. 1.29M 1.40% 1.29M 10.00 PN Cayman Islands, British West Indies 2017-11-16
22 STARBOARD VALUE R GP LLC 648.3K 1.00% 648.3K OO 2021-08-31
23 Elliott Associates, L.P. 608.0K 0.70% 608.0K 608.0K 10.00 PN Delaware 2017-11-16
24 STARBOARD VALUE AND OPPORTUNITY S LLC 575.3K 1.00% 575.3K OO 2021-08-31
25 STARBOARD X MASTER FUND LTD 457.3K 1.00% 457.3K CO 2021-08-31
26 STARBOARD VALUE AND OPPORTUNITY C LP 334.4K 1.00% 334.4K PN 2021-08-31
27 STARBOARD VALUE R LP 334.4K 1.00% 334.4K PN 2021-08-31
28 STARBOARD VALUE AND OPPORTUNITY MASTER FUND L LP 313.9K 1.00% 313.9K PN 2021-08-31
29 STARBOARD VALUE L LP 313.9K 1.00% 313.9K PN 2021-08-31

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
66
-232 vs prev Q
New positions
9
Closed positions
241
Increased
20
Reduced
26
Put/Call ratio
0.00
Calls held
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 BLACKROCK, INC. 13.56M -287.0K (-2.1%) 290.10M +58.1M (+25.1%) 15.89% -0.058 pp 0.00% +0.001 pp USD11.63 +83.9% 6 qtrs
2 VANGUARD GROUP INC 10.72M -168.6K (-1.5%) 229.39M +46.9M (+25.7%) 12.56% +0.021 pp 0.00% +0.001 pp USD29.36 -27.1% 68 qtrs
3 VICTORY CAPITAL MANAGEMENT INC 3.82M -307.9K (-7.5%) 81.67M +12.6M (+18.2%) 4.47% -0.278 pp 0.05% +0.006 pp USD14.89 +43.7% 32 qtrs
4 AMERICAN CENTURY COMPANIES INC 3.70M +1.0M (+37.8%) 79.10M +34.2M (+76.0%) 4.33% +1.243 pp 0.04% +0.017 pp USD16.16 +32.4% 11 qtrs
5 DIMENSIONAL FUND ADVISORS LP 3.57M +169.4K (+5.0%) 76.35M +19.4M (+34.1%) 4.18% +0.267 pp 0.02% +0.004 pp USD31.01 -31.0% 51 qtrs
6 STATE STREET CORP 3.31M -218.6K (-6.2%) 70.85M +11.7M (+19.8%) 3.88% -0.185 pp 0.00% +0.000 pp USD33.27 -35.7% 51 qtrs
7 FMR LLC 2.43M +224.2K (+10.2%) 51.95M +15.0M (+40.7%) 2.85% +0.307 pp 0.00% +0.001 pp USD13.89 +54.0% 68 qtrs
8 GEODE CAPITAL MANAGEMENT, LLC 2.18M +14.4K (+0.7%) 46.67M +10.4M (+28.6%) 2.56% +0.060 pp 0.00% +0.001 pp USD27.38 -21.9% 68 qtrs
9 D. E. SHAW & CO., INC. 1.85M -169.1K (-8.4%) 39.62M +5.8M (+17.0%) 2.17% -0.158 pp 0.02% +0.003 pp USD17.62 +21.4% 34 qtrs
10 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.55M +105.3K (+7.3%) 33.21M +9.0M (+37.0%) 1.82% +0.152 pp 0.01% +0.001 pp USD22.42 -4.6% 68 qtrs
11 RENAISSANCE TECHNOLOGIES LLC 1.36M +51.7K (+4.0%) 29.04M +7.2M (+32.8%) 1.59% +0.087 pp 0.05% +0.016 pp USD13.21 +61.9% 12 qtrs
12 MORGAN STANLEY 1.30M +24.7K (+1.9%) 27.89M +6.5M (+30.2%) 1.53% +0.055 pp 0.00% +0.000 pp USD11.15 +91.8% 51 qtrs
13 FULLER & THALER ASSET MANAGEMENT, INC. 1.23M +1.2M (+100.0%) 26.30M +26.3M (+100.0%) 1.44% +1.440 pp 0.09% +0.089 pp USD21.39 +0.0% 1 qtrs NEW
14 NUVEEN, LLC 1.20M -351.1K (-22.6%) 25.67M -311.4K (-1.2%) 1.41% -0.380 pp 0.01% 0.000 pp USD15.50 +38.0% 4 qtrs
15 INVESCO LTD. 1.09M +213.6K (+24.4%) 23.33M +8.6M (+58.8%) 1.28% +0.268 pp 0.00% +0.001 pp USD16.95 +26.2% 57 qtrs
16 SILVERCREST ASSET MANAGEMENT GROUP LLC 1.03M +1.0M (+100.0%) 22.08M +22.1M (+100.0%) 1.21% +1.209 pp 0.15% +0.152 pp USD21.39 +0.0% 1 qtrs NEW
17 NORTHERN TRUST CORP 872.3K -60.3K (-6.5%) 18.66M +3.0M (+19.4%) 1.02% -0.052 pp 0.00% +0.000 pp USD29.38 -27.2% 51 qtrs
18 ALLIANCEBERNSTEIN L.P. 815.8K -24.1K (-2.9%) 17.45M +3.4M (+24.0%) 0.96% -0.011 pp 0.01% +0.001 pp USD21.49 -0.5% 61 qtrs
19 BOSTON PARTNERS 797.7K -630.3K (-44.1%) 17.20M -6.9M (-28.5%) 0.93% -0.710 pp 0.02% -0.007 pp USD10.25 +108.7% 9 qtrs
20 GOLDMAN SACHS GROUP INC 787.3K +20.7K (+2.7%) 16.84M +4.0M (+31.2%) 0.92% +0.040 pp 0.00% +0.001 pp USD12.69 +68.6% 68 qtrs
21 BRIDGEWAY CAPITAL MANAGEMENT, LLC 740.3K +93.5K (+14.5%) 15.83M +5.0M (+46.2%) 0.87% +0.123 pp 0.33% +0.101 pp USD11.82 +81.0% 9 qtrs
22 QUBE RESEARCH & TECHNOLOGIES LTD 727.3K -416.0K (-36.4%) 15.56M -3.6M (-18.8%) 0.85% -0.464 pp 0.02% -0.004 pp USD13.17 +62.4% 12 qtrs
23 JPMORGAN CHASE & CO 710.7K -116.4K (-14.1%) 15.20M +1.3M (+9.7%) 0.83% -0.120 pp 0.00% +0.000 pp USD11.90 +79.7% 51 qtrs
24 AMERIPRISE FINANCIAL INC 670.7K -1.0K (-0.1%) 14.35M +3.1M (+27.5%) 0.79% +0.012 pp 0.00% +0.001 pp USD19.24 +11.2% 51 qtrs
25 DANA INVESTMENT ADVISORS, INC. 648.7K -152.7K (-19.1%) 13.88M +451.7K (+3.4%) 0.76% -0.163 pp 0.40% +0.011 pp USD9.00 +137.7% 8 qtrs
26 ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 639.4K +639.4K (+100.0%) 13.61M +13.6M (+100.0%) 0.75% +0.749 pp 0.02% +0.022 pp USD21.39 +0.0% 1 qtrs NEW
27 EMPOWERED FUNDS, LLC 622.4K +93.8K (+17.8%) 13.31M +4.5M (+50.4%) 0.73% +0.121 pp 0.11% +0.016 pp USD13.39 +59.7% 9 qtrs
28 ROCKEFELLER CAPITAL MANAGEMENT L.P. 594.4K +529.4K (+814.6%) 12.71M +11.6M (+1,068.0%) 0.70% +0.621 pp 0.02% +0.021 pp USD20.88 +2.4% 2 qtrs
29 BANK OF NEW YORK MELLON CORP 587.1K -14.7K (-2.5%) 12.56M +2.5M (+24.6%) 0.69% -0.005 pp 0.00% +0.000 pp USD41.64 -48.6% 66 qtrs
30 UBS GROUP AG 585.8K +276.6K (+89.5%) 12.53M +7.4M (+142.0%) 0.69% +0.330 pp 0.00% +0.001 pp USD17.16 +24.7% 45 qtrs
31 ARROWMARK COLORADO HOLDINGS LLC 566.3K -40.2K (-6.6%) 12.11M +2.0M (+19.2%) 0.66% -0.035 pp 0.27% +0.078 pp USD20.22 +5.8% 38 qtrs
32 OBERWEIS ASSET MANAGEMENT INC/ 560.0K +14.4K (+2.6%) 11.98M +2.8M (+31.1%) 0.66% +0.028 pp 0.44% +0.088 pp USD13.53 +58.1% 5 qtrs
33 AQR CAPITAL MANAGEMENT LLC 551.8K +24.6K (+4.7%) 11.80M +3.1M (+36.4%) 0.65% +0.039 pp 0.01% +0.001 pp USD13.99 +52.9% 17 qtrs
34 BANK OF AMERICA CORP /DE/ 529.6K -14.4K (-2.7%) 11.33M +2.2M (+24.3%) 0.62% -0.006 pp 0.00% +0.000 pp USD13.66 +56.6% 52 qtrs
35 PANAGORA ASSET MANAGEMENT INC 520.1K +16.5K (+3.3%) 11.13M +2.7M (+31.9%) 0.61% +0.030 pp 0.04% +0.005 pp USD13.13 +62.9% 6 qtrs
36 PACER ADVISORS, INC. 494.4K -116.5K (-19.1%) 10.57M +342.1K (+3.3%) 0.58% -0.124 pp 0.03% +0.001 pp USD13.12 +63.0% 5 qtrs
37 PRINCIPAL FINANCIAL GROUP INC 474.5K +13.7K (+3.0%) 10.15M +2.4M (+31.5%) 0.56% +0.025 pp 0.01% +0.001 pp USD28.23 -24.2% 68 qtrs
38 LSV ASSET MANAGEMENT 462.2K +156.4K (+51.1%) 9.89M +4.8M (+93.0%) 0.54% +0.189 pp 0.02% +0.010 pp USD16.66 +28.4% 12 qtrs
39 HILLSDALE INVESTMENT MANAGEMENT INC. 450.4K -1.8K (-0.4%) 9.63M +2.1M (+27.2%) 0.53% +0.007 pp 0.27% +0.037 pp USD14.75 +45.0% 5 qtrs
40 BRANDES INVESTMENT PARTNERS, LP 442.3K -188.4K (-29.9%) 9.46M -1.1M (-10.5%) 0.52% -0.208 pp 0.07% -0.013 pp USD13.65 +56.7% 33 qtrs
41 ARISTOTLE CAPITAL BOSTON, LLC 440.1K -43.9K (-9.1%) 9.41M +1.3M (+16.1%) 0.52% -0.042 pp 0.52% +0.099 pp USD30.45 -29.8% 45 qtrs
42 CASTLEKNIGHT MANAGEMENT LP 396.1K -285.9K (-41.9%) 8.47M -3.0M (-25.8%) 0.46% -0.321 pp 0.19% -0.037 pp USD11.04 +93.8% 7 qtrs
43 PUBLIC SECTOR PENSION INVESTMENT BOARD 386.1K -23.6K (-5.7%) 8.26M +1.4M (+20.4%) 0.45% -0.019 pp 0.03% +0.003 pp USD16.44 +30.1% 21 qtrs
44 BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC 344.0K -12.8K (-3.6%) 7.36M +1.4M (+23.1%) 0.40% -0.008 pp 0.05% +0.008 pp USD14.35 +49.1% 3 qtrs
45 PHOCAS FINANCIAL CORP. 335.6K +103.3K (+44.5%) 7.18M +3.3M (+84.5%) 0.39% +0.126 pp 0.93% +0.429 pp USD18.18 +17.7% 2 qtrs
46 CSM ADVISORS, LLC 330.2K +16.5K (+5.3%) 7.06M +1.8M (+34.5%) 0.39% +0.026 pp 0.19% +0.045 pp USD15.51 +37.9% 3 qtrs
47 TEACHER RETIREMENT SYSTEM OF TEXAS 306.7K +62.4K (+25.6%) 6.56M +2.5M (+60.3%) 0.36% +0.078 pp 0.02% +0.006 pp USD16.20 +32.0% 5 qtrs
48 ENVESTNET ASSET MANAGEMENT INC 286.2K +273.5K (+2,153.9%) 6.12M +5.9M (+2,778.2%) 0.34% +0.321 pp 0.00% +0.002 pp USD21.18 +1.0% 2 qtrs
49 PRUDENTIAL FINANCIAL INC 279.9K -43.9K (-13.6%) 5.99M +563.7K (+10.4%) 0.33% -0.045 pp 0.01% +0.001 pp USD12.50 +71.1% 68 qtrs
50 RAYMOND JAMES FINANCIAL INC 274.9K +27.5K (+11.1%) 5.88M +1.7M (+41.9%) 0.32% +0.037 pp 0.00% +0.001 pp USD14.01 +52.7% 5 qtrs
51 ALLIANZ ASSET MANAGEMENT GMBH 265.3K +106.6K (+67.1%) 5.68M +3.0M (+113.4%) 0.31% +0.128 pp 0.01% +0.003 pp USD17.81 +20.1% 18 qtrs
52 ROYCE & ASSOCIATES LP 254.7K +75.7K (+42.3%) 5.45M +2.5M (+81.7%) 0.30% +0.092 pp 0.06% +0.025 pp USD14.33 +49.3% 11 qtrs
53 DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN 250.0K -43.6K (-14.9%) 5.35M +429.2K (+8.7%) 0.29% -0.045 pp 0.00% +0.000 pp USD14.35 +49.1% 3 qtrs
54 LORD, ABBETT & CO. LLC 247.7K +247.7K (+100.0%) 5.30M +5.3M (+100.0%) 0.29% +0.290 pp 0.02% +0.016 pp USD21.39 +0.0% 1 qtrs NEW
55 NORDEA INVESTMENT MANAGEMENT AB 239.9K -34.9K (-12.7%) 5.18M +687.8K (+15.3%) 0.28% -0.035 pp 0.00% +0.001 pp USD21.00 +1.9% 58 qtrs
56 UBS ASSET MANAGEMENT AMERICAS INC 240.0K +1.7K (+0.7%) 5.13M +1.1M (+28.6%) 0.28% +0.007 pp 0.00% +0.000 pp USD12.25 +74.6% 68 qtrs
57 LEGAL & GENERAL GROUP PLC 215.4K -15.6K (-6.8%) 4.61M +737.8K (+19.1%) 0.25% -0.014 pp 0.00% +0.000 pp USD33.86 -36.8% 60 qtrs
58 O'SHAUGHNESSY ASSET MANAGEMENT, LLC 198.3K +183.1K (+1,203.5%) 4.24M +4.0M (+1,564.5%) 0.23% +0.215 pp 0.02% +0.022 pp USD20.80 +2.8% 5 qtrs
59 SEI INVESTMENTS CO 195.0K +12.1K (+6.6%) 4.17M +1.1M (+36.1%) 0.23% +0.018 pp 0.00% +0.001 pp USD26.52 -19.3% 45 qtrs
60 ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 192.5K +23.2K (+13.7%) 4.12M +1.3M (+45.2%) 0.23% +0.031 pp 0.00% +0.001 pp USD15.20 +40.7% 3 qtrs
61 RHUMBLINE ADVISERS 186.1K -30.3K (-14.0%) 3.98M +356.4K (+9.8%) 0.22% -0.031 pp 0.00% +0.000 pp USD30.92 -30.8% 51 qtrs
62 EAM INVESTORS, LLC 182.7K +182.7K (+100.0%) 3.91M +3.9M (+100.0%) 0.21% +0.214 pp 0.44% +0.435 pp USD21.39 +0.0% 1 qtrs NEW
63 RUSSELL INVESTMENTS GROUP, LTD. 177.7K +25.8K (+17.0%) 3.80M +1.3M (+49.4%) 0.21% +0.033 pp 0.00% +0.001 pp USD14.88 +43.8% 37 qtrs
64 TREXQUANT INVESTMENT LP 174.2K -37.1K (-17.6%) 3.73M +186.3K (+5.3%) 0.20% -0.039 pp 0.03% -0.003 pp USD16.75 +27.7% 10 qtrs
65 SWISS NATIONAL BANK 171.8K +5.3K (+3.2%) 3.67M +885.9K (+31.8%) 0.20% +0.010 pp 0.00% +0.001 pp USD45.09 -52.6% 51 qtrs
66 MARTINGALE ASSET MANAGEMENT L P 169.6K -8.6K (-4.8%) 3.63M +643.4K (+21.6%) 0.20% -0.007 pp 0.09% +0.017 pp USD13.50 +58.4% 12 qtrs
67 CASTLEARK MANAGEMENT LLC 159.1K +159.1K (+100.0%) 3.40M +3.4M (+100.0%) 0.19% +0.186 pp 0.10% +0.100 pp USD21.39 +0.0% 1 qtrs NEW
68 BARCLAYS PLC 158.5K +16.5K (+11.6%) 3.39M +1.7M (+105.9%) 0.19% +0.022 pp 0.00% +0.000 pp USD13.77 +55.3% 51 qtrs
69 BRIDGE CITY CAPITAL, LLC 149.9K -87.0K (-36.7%) 3.21M -761.2K (-19.2%) 0.18% -0.097 pp 0.94% -0.117 pp USD19.53 +9.5% 34 qtrs
70 BESSEMER GROUP INC 147.2K +146.1K (+13,365.3%) 3.15M +3.1M (+16,468.4%) 0.17% +0.171 pp 0.00% +0.005 pp USD21.32 +0.3% 8 qtrs
71 FIRST TRUST ADVISORS LP 146.1K +146.1K (+100.0%) 3.13M +3.1M (+100.0%) 0.17% +0.171 pp 0.00% +0.002 pp USD21.39 +0.0% 1 qtrs NEW
72 BNP PARIBAS ARBITRAGE, SNC 143.9K -327.8K (-69.5%) 3.08M -4.8M (-61.0%) 0.17% -0.375 pp 0.00% -0.003 pp USD14.26 +50.0% 49 qtrs
73 SEGALL BRYANT & HAMILL, LLC 142.9K -769.0 (-0.5%) 3.06M +650.4K (+27.0%) 0.17% +0.002 pp 0.04% +0.009 pp USD15.17 +41.0% 25 qtrs
74 LAZARD ASSET MANAGEMENT LLC 138.4K +35.3K (+34.3%) 2.96M +1.2M (+71.5%) 0.16% +0.044 pp 0.01% +0.003 pp USD16.39 +30.5% 5 qtrs
75 NEW YORK STATE TEACHERS RETIREMENT SYSTEM 134.8K -6.8K (-4.8%) 2.88M +511.0K (+21.6%) 0.16% -0.005 pp 0.01% +0.001 pp USD37.55 -43.0% 51 qtrs
76 CLARK ESTATES INC/NY 129.0K -42.3K (-24.7%) 2.76M -110.2K (-3.8%) 0.15% -0.046 pp 0.67% +0.014 pp USD9.30 +130.0% 9 qtrs
77 ENGINEERS GATE MANAGER LP 125.1K -25.7K (-17.0%) 2.68M +149.9K (+5.9%) 0.15% -0.027 pp 0.03% +0.003 pp USD13.40 +59.6% 28 qtrs
78 WEDGE CAPITAL MANAGEMENT L L P/NC 124.1K -14.2K (-10.3%) 2.65M +338.1K (+14.6%) 0.15% -0.014 pp 0.05% +0.008 pp USD16.75 +27.7% 2 qtrs
79 WELLS FARGO & COMPANY/MN 120.2K +41.1K (+52.0%) 2.57M +1.2M (+94.1%) 0.14% +0.050 pp 0.00% +0.000 pp USD22.60 -5.4% 57 qtrs
80 RBF CAPITAL, LLC 120.0K -10.0K (-7.7%) 2.57M +389.3K (+17.9%) 0.14% -0.009 pp 0.11% +0.017 pp USD11.59 +84.6% 6 qtrs
81 BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 119.2K +118.2K (+11,770.0%) 2.55M +2.5M (+14,894.1%) 0.14% +0.138 pp 0.00% +0.003 pp USD21.33 +0.3% 3 qtrs
82 HSBC HOLDINGS PLC 115.7K -16.5K (-12.5%) 2.49M +302.2K (+13.8%) 0.14% -0.017 pp 0.00% +0.000 pp USD13.88 +54.1% 9 qtrs
83 GREAT LAKES ADVISORS, LLC 115.7K -52.4K (-31.2%) 2.47M -341.3K (-12.1%) 0.14% -0.058 pp 0.02% -0.003 pp USD14.35 +49.1% 3 qtrs
84 NEW YORK STATE COMMON RETIREMENT FUND 115.2K -1.7K (-1.5%) 2.46M +506.0K (+25.8%) 0.14% +0.000 pp 0.00% +0.001 pp USD20.55 +4.1% 68 qtrs
85 GOTHAM ASSET MANAGEMENT, LLC 112.9K -3.2K (-2.8%) 2.41M +469.4K (+24.1%) 0.13% -0.002 pp 0.01% +0.000 pp USD13.29 +60.9% 12 qtrs
86 JANE STREET GROUP, LLC 110.8K -110.8K (-50.0%) 2.37M -1.3M (-36.2%) 0.13% -0.125 pp 0.00% 0.000 pp USD10.96 +95.2% 29 qtrs
87 CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 108.5K -109.9K (-50.3%) 2.32M -1.3M (-36.5%) 0.13% -0.124 pp 0.01% -0.005 pp USD14.24 +50.2% 14 qtrs
88 JACKSON CREEK INVESTMENT ADVISORS LLC 105.9K -4.2K (-3.9%) 2.27M +420.0K (+22.8%) 0.12% -0.003 pp 0.67% +0.135 pp USD14.35 +49.1% 3 qtrs
89 RITHOLTZ WEALTH MANAGEMENT 101.1K +101.1K (+100.0%) 2.16M +2.2M (+100.0%) 0.12% +0.118 pp 0.04% +0.040 pp USD21.39 +0.0% 5 qtrs
90 XTX TOPCO LTD 99.9K +82.8K (+483.4%) 2.14M +1.8M (+645.1%) 0.12% +0.097 pp 0.06% +0.041 pp USD20.15 +6.2% 5 qtrs
91 NOMURA HOLDINGS INC 97.6K -66.9K (-40.6%) 2.09M -666.8K (-24.2%) 0.11% -0.075 pp 0.00% -0.002 pp USD13.79 +55.1% 5 qtrs
92 PRICE T ROWE ASSOCIATES INC /MD/ 86.6K +3.8K (+4.6%) 1.85M +465.0K (+33.5%) 0.10% +0.006 pp 0.00% +0.000 pp USD24.73 -13.5% 68 qtrs
93 ZACKS INVESTMENT MANAGEMENT 83.8K -5.9K (-6.6%) 1.79M +289.9K (+19.3%) 0.10% -0.005 pp 0.01% +0.002 pp USD16.75 +27.7% 2 qtrs
94 ROYAL BANK OF CANADA 83.0K +74.9K (+921.3%) 1.78M +1.6M (+1,195.6%) 0.10% +0.088 pp 0.00% +0.000 pp USD20.57 +4.0% 51 qtrs
95 CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 82.6K +3.3K (+4.1%) 1.77M +438.4K (+33.0%) 0.10% +0.005 pp 0.00% +0.000 pp USD42.01 -49.1% 52 qtrs
96 INTEGRATED QUANTITATIVE INVESTMENTS LLC 79.6K +5.5K (+7.4%) 1.70M +461.0K (+37.2%) 0.09% +0.008 pp 0.37% +0.013 pp USD14.97 +42.9% 4 qtrs
97 CITADEL ADVISORS LLC 78.1K -14.4K (-15.6%) 1.67M +121.1K (+7.8%) 0.09% -0.015 pp 0.00% +0.000 pp USD12.65 +69.1% 18 qtrs
98 EXCHANGE TRADED CONCEPTS, LLC 77.1K +6.3K (+8.9%) 1.65M +462.9K (+39.0%) 0.09% +0.009 pp 0.01% +0.003 pp USD17.13 +24.9% 2 qtrs
99 MILLENNIUM MANAGEMENT LLC 76.1K -88.0K (-53.6%) 1.63M -1.1M (-40.8%) 0.09% -0.100 pp 0.00% -0.001 pp USD13.69 +56.2% 19 qtrs
100 FRANKLIN RESOURCES INC 75.5K +4.6K (+6.6%) 1.62M +428.2K (+36.1%) 0.09% +0.007 pp 0.00% +0.000 pp USD13.23 +61.7% 6 qtrs
Ownership breakdown by holder

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.50
Neutral
Ratio by volume
1.30
Neutral
Buys
1
Sells
2
Shares acquired
39.9K
Shares disposed
30.6K
Cash buys
Cash sales
Net activity
+9,318
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-03-01 Rossi Kasandra H Officer F-InKind D Common Stock 3,676 19.85 73.0K 73,300 D
2026-03-01 Moore Mary Ann E Officer A-Award A Common Stock 39,925 0.00 176,167 D
2025-12-15 ORDAN MARK S Director / Officer S-Sale D Common Stock 23,000 22.41 515.4K 302,805 D
2025-11-17 Rucker Michael A. Director S-Sale D Common Stock 10,478 23.00 241.0K 59,101 D
2025-11-06 Linynsky Laura A Director S-Sale D Common Stock 10,000 21.65 216.5K 32,232 D
2025-08-20 McEachin Thomas Director G-Gift D Common Stock 625 0.00 11,427 D
2025-08-19 McEachin Thomas Director G-Gift D Common Stock 54,021 0.00 12,052 D
2025-08-01 Newman Kurt Douglas Director A-Award A Common Stock 9,737 0.00 9,737 D
2025-08-01 Neeb Don Gregory Officer A-Award A Common Stock 81,346 0.00 81,346 D
2025-07-01 Newman Kurt Douglas 0 0.00 0
2025-06-10 Moore Mary Ann E Officer G-Gift D Common Stock 10,371 0.00 136,242 D
2025-06-01 Rossi Kasandra H Officer A-Award A Common Stock 26,502 0.00 77,653 D
2025-06-01 ORDAN MARK S Director / Officer A-Award A Common Stock 194,347 0.00 325,805 D
2025-06-01 Moore Mary Ann E Officer A-Award A Common Stock 53,004 0.00 153,342 D
2025-05-23 Weis Shirley A Director G-Gift D Common Stock 18,360 0.00 11,427 D
2025-05-09 ORDAN MARK S Director / Officer F-InKind D Common Stock 7,225 14.44 104.3K 131,458 D
2025-05-08 Young Sylvia Jean Director A-Award A Common Stock 11,427 0.00 40,618 D
2025-05-08 Weis Shirley A Director A-Award A Common Stock 11,427 0.00 29,787 D
2025-05-08 Starcher John M. Jr. Director A-Award A Common Stock 11,427 0.00 66,064 D
2025-05-08 SANSONE GUY P Director A-Award A Common Stock 11,427 0.00 79,748 D
2025-05-08 Rucker Michael A. Director A-Award A Common Stock 11,427 0.00 69,579 D
2025-05-08 McEachin Thomas Director A-Award A Common Stock 11,427 0.00 66,073 D
2025-05-08 Linynsky Laura A Director A-Award A Common Stock 11,427 0.00 42,232 D
2025-03-06 Moore Mary Ann E Officer G-Gift D Common Stock 26,497 0.00 100,338 D
2025-03-01 Rossi Kasandra H Officer F-InKind D Common Stock 3,718 14.77 54.9K 51,151 D
2025-03-01 Moore Mary Ann E Officer F-InKind D Common Stock 8,975 14.77 132.6K 126,835 D
2025-02-25 Weis Shirley A Director G-Gift D Common Stock 17,668 0.00 18,360 D
2025-01-12 ORDAN MARK S Director / Officer A-Award A Performance Share Unit 640,000 0.00 640,000 D
2024-12-01 Rossi Kasandra H Officer A-Award A Common Stock 11,112 0.00 54,869 D
2024-11-13 ORDAN MARK S Director S-Sale D Common Stock 27,600 15.35 423.7K 138,683 D
2024-11-08 Moore Mary Ann E Officer S-Sale D Common Stock 8,108 16.00 129.7K 135,810 D
2024-10-01 Rossi Kasandra H Officer Common Stock 0 0.00 43,757 D
2024-08-30 Swift James D Director / Officer S-Sale D Common Stock 11,100 10.79 119.8K 170,001
2024-08-27 Linynsky Laura A Director S-Sale D Common Stock 7,000 11.16 78.1K 30,805
2024-08-12 Richards C Marc Officer S-Sale D Common Stock 17,438 10.08 175.8K 175,347
2024-08-09 Richards C Marc Officer S-Sale D Common Stock 32,562 10.08 328.2K 192,785
2024-06-01 Wood Lee Officer A-Award A Common Stock 51,300 0.00 118,094
2024-06-01 Swift James D Director / Officer A-Award A Common Stock 105,165 0.00 181,101
2024-06-01 Richards C Marc Officer A-Award A Common Stock 95,760 0.00 225,347
2024-06-01 Pickert Curtis Officer A-Award A Common Stock 68,400 0.00 121,401
2024-06-01 Moore Mary Ann E Officer A-Award A Common Stock 68,400 0.00 143,918
2024-05-09 Young Sylvia Jean Director A-Award A Common Stock 18,360 0.00 29,191
2024-05-09 Weis Shirley A Director A-Award A Common Stock 18,360 0.00 36,028
2024-05-09 Starcher John M. Jr. Director A-Award A Common Stock 18,360 0.00 54,637
2024-05-09 SANSONE GUY P Director A-Award A Common Stock 18,360 0.00 68,321
2024-05-09 Rucker Michael A. Director A-Award A Common Stock 18,360 0.00 58,152
2024-05-09 ORDAN MARK S Director A-Award A Common Stock 18,360 0.00 166,283
2024-05-09 McEachin Thomas Director A-Award A Common Stock 18,360 0.00 54,646
2024-05-09 Linynsky Laura A Director A-Award A Common Stock 18,360 0.00 37,805
2024-03-13 Pickert Curtis Officer G-Gift D Common Stock 12,923 0.00 53,001
2024-03-01 Wood Lee Officer F-InKind D Common Stock 4,962 9.15 45.4K 66,794
2024-03-01 Swift James D Director / Officer F-InKind D Common Stock 14,938 9.15 136.7K 75,936
2024-03-01 Richards C Marc Officer F-InKind D Common Stock 21,428 9.15 196.1K 129,587
2024-03-01 Pickert Curtis Officer F-InKind D Common Stock 9,160 9.15 83.8K 65,924
2024-03-01 Moore Mary Ann E Officer F-InKind D Common Stock 5,867 9.15 53.7K 75,518
2023-12-14 Swift James D Director / Officer S-Sale D Common Stock 5,764 9.58 55.2K 90,874
2023-12-14 Moore Mary Ann E Officer S-Sale D Common Stock 970 9.62 9.3K 81,385
2023-06-14 Swift James D Director / Officer S-Sale D Common Stock 13,193 14.14 186.5K 96,638
2023-06-07 Pickert Curtis Officer G-Gift D Common Stock 1,166 0.00 75,084
2023-06-01 Wood Lee Officer F-InKind D Common Stock 407 13.30 5.4K 71,756
2023-06-01 Pickert Curtis Officer F-InKind D Common Stock 376 13.30 5.0K 76,250
2023-05-25 ORDAN MARK S Director S-Sale D Common Stock 33,000 13.26 437.6K 147,923
2023-05-19 Weis Shirley A Director S-Sale D Common Stock 1,007 13.63 13.7K 17,668
2023-05-18 Weis Shirley A Director S-Sale D Common Stock 17,993 13.55 243.8K 18,675
2023-05-15 Pickert Curtis Officer G-Gift D Common Stock 5,984 0.00 76,626
2023-05-12 Young Sylvia Jean Director A-Award A Common Stock 10,831 0.00 10,831
2023-05-11 Weis Shirley A Director A-Award A Common Stock 10,965 0.00 36,668
2023-05-11 Starcher John M. Jr. Director A-Award A Common Stock 10,965 0.00 36,277
2023-05-11 SANSONE GUY P Director A-Award A Common Stock 10,965 0.00 49,961
2023-05-11 Rucker Michael A. Director A-Award A Common Stock 10,965 0.00 39,792
2023-05-11 ORDAN MARK S Director A-Award A Common Stock 9,463 0.00 180,923
2023-05-11 McEachin Thomas Director A-Award A Common Stock 10,965 0.00 36,286
2023-05-11 Linynsky Laura A Director A-Award A Common Stock 10,965 0.00 19,445
2023-03-01 Wood Lee Officer A-Award A Common Stock 39,806 0.00 74,207
2023-03-01 Swift James D Officer A-Award A Common Stock 49,758 0.00 119,740
2023-03-01 Richards C Marc Officer F-InKind D Common Stock 9,991 15.74 157.3K 151,015
2023-03-01 Pickert Curtis Officer F-InKind D Common Stock 2,300 15.74 36.2K 82,610
2023-03-01 Moore Mary Ann E Officer A-Award A Common Stock 55,664 0.00 84,700
2023-02-13 Wood Lee Officer D Common Stock 0 0.00 34,401
2023-02-13 Pickert Curtis Officer D Common Stock 0 0.00 29,246
2022-12-31 ORDAN MARK S Officer F-InKind D Common Stock 98,932 14.86 1.47M 247,713
2022-11-21 ORDAN MARK S Officer S-Sale D Common Stock 22,166 15.45 342.5K 346,645
2022-11-07 Swift James D Officer S-Sale D Common Stock 24,000 15.31 367.4K 87,956
2022-09-26 Andreano Dominic J Officer F-InKind D Common Stock 4,267 16.81 71.7K 189,440
2022-05-12 Weis Shirley A Director A-Award A Common Stock 8,480 0.00 25,703
2022-05-12 Starcher John M. Jr. Director A-Award A Common Stock 8,480 0.00 25,312
2022-05-12 SANSONE GUY P Director A-Award A Common Stock 8,480 0.00 38,996
2022-05-12 Rucker Michael A. Director A-Award A Common Stock 8,480 0.00 28,827
2022-05-12 McEachin Thomas Director A-Award A Common Stock 8,480 0.00 25,321
2022-05-12 MEDEL ROGER MD Director A-Award A Common Stock 8,480 0.00 747,930
2022-05-12 Linynsky Laura A Director 0 0.00 0
2022-03-01 Richards C Marc Officer F-InKind D Common Stock 6,874 23.47 161.3K 146,199
2022-03-01 ORDAN MARK S Director / Officer A-Award A Common Stock 76,253 0.00 313,249
2022-03-01 Moore Mary Ann E Officer A-Award A Common Stock 16,340 0.00 30,561
2022-03-01 Hinson Roger Mack Officer F-InKind D Common Stock 10,244 23.47 240.4K 109,457
2022-03-01 Andreano Dominic J Officer A-Award A Common Stock 29,412 0.00 170,930
2022-01-11 MEDEL ROGER MD Director S-Sale D Common Stock 40,107 26.58 1.07M 739,450
2022-01-10 MEDEL ROGER MD Director S-Sale D Common Stock 59,893 26.44 1.58M 779,557
2022-01-05 MEDEL ROGER MD Director S-Sale D Common Stock 12,639 27.42 346.6K 839,450
2022-01-04 MEDEL ROGER MD Director S-Sale D Common Stock 87,361 27.43 2.40M 852,089
2021-12-31 MEDEL ROGER MD Director S-Sale D Common Stock 6,564 27.16 178.3K 939,450
2021-12-30 MEDEL ROGER MD Director S-Sale D Common Stock 45,397 27.19 1.23M 946,014
2021-12-29 MEDEL ROGER MD Director S-Sale D Common Stock 25,000 27.28 682.0K 991,411
2021-12-28 MEDEL ROGER MD Director S-Sale D Common Stock 44,514 27.28 1.21M 1,016,411
2021-12-27 MEDEL ROGER MD Director S-Sale D Common Stock 66,868 27.17 1.82M 1,060,925
2021-11-16 Moore Mary Ann E Officer I Common Stock 0 0.00 16,880
2021-11-10 Pepia John C Officer S-Sale D Common Stock 5,000 28.45 142.3K 96,666
2021-11-10 Hinson Roger Mack Officer S-Sale D Common Stock 8,800 28.38 249.7K 107,391
2021-10-29 Pepia John C Officer S-Sale D Common Stock 9,238 26.87 248.2K 101,666
2021-10-28 MEDEL ROGER MD Director S-Sale D Common Stock 10,387 29.00 301.2K 1,127,793
2021-10-04 MEDEL ROGER MD Director S-Sale D Common Stock 1,270 29.00 36.8K 1,138,180
2021-09-26 Richards C Marc Officer D Employee Stock Options (right to buy) 192,400 16.14 3.11M 0
2021-09-26 Hinson Roger Mack Officer D Employee Stock Option (right to buy) 144,000 16.14 2.32M 0
2021-09-02 Pepia John C Officer S-Sale D Common Stock 10,000 31.83 318.3K 110,843
2021-08-30 ORDAN MARK S Director / Officer S-Sale D Common Stock 95,000 35.09 3.33M 208,425
2021-08-10 Hinson Roger Mack Officer S-Sale D Common Stock 8,799 32.35 284.6K 116,129
2021-07-12 MEDEL ROGER MD Director F-InKind D Common Stock 83,092 29.77 2.47M 1,139,450
2021-07-01 MEDEL ROGER MD Director S-Sale D Common Stock 100,000 30.31 3.03M 1,222,542
2021-06-01 Pepia John C Officer F-InKind D Common Stock 7,858 31.98 251.3K 120,785
2021-05-12 Weis Shirley A Director A-Award A Common Stock 4,885 0.00 17,223
2021-05-12 WALDEMAR, MD CARLO A Director A-Award A Common Stock 4,885 0.00 36,687
2021-05-12 Starcher John M. Jr. Director A-Award A Common Stock 4,885 0.00 16,832
2021-05-12 SANSONE GUY P Director A-Award A Common Stock 4,885 0.00 30,516
2021-05-12 Rucker Michael A. Director A-Award A Common Stock 4,885 0.00 20,347
2021-05-12 McEachin Thomas Director A-Award A Common Stock 4,885 0.00 16,841
2021-05-12 MEDEL ROGER MD Director A-Award A Common Stock 4,885 0.00 1,322,542
2021-05-12 Kadre Manuel Director A-Award A Common Stock 4,885 0.00 129,198
2021-05-12 GABOS PAUL G Director A-Award A Common Stock 4,885 0.00 29,198
2021-05-12 Barker Karey D Director A-Award A Common Stock 4,885 0.00 22,663
2021-04-01 MEDEL ROGER MD Director S-Sale D Common Stock 99,218 25.40 2.52M 1,318,439
2021-03-01 Richards C Marc Officer A-Award A Common Stock 28,571 0.00 52,069
2021-03-01 Pepia John C Officer A-Award A Common Stock 10,204 0.00 120,653
2021-03-01 ORDAN MARK S Director / Officer A-Award A Common Stock 71,429 0.00 136,996
2021-03-01 MEDEL ROGER MD Director F-InKind D Common Stock 72,575 24.43 1.77M 1,417,657
2021-03-01 Hinson Roger Mack Officer F-InKind D Common Stock 6,244 24.43 152.5K 124,800
2021-03-01 Andreano Dominic J Officer A-Award A Common Stock 27,551 0.00 102,945
2021-01-04 MEDEL ROGER MD Director S-Sale D Common Stock 47,039 23.41 1.10M 1,543,193
2020-12-10 MEDEL ROGER MD Director S-Sale D Common Stock 33,194 23.04 764.9K 1,590,232
2020-12-09 MEDEL ROGER MD Director S-Sale D Common Stock 66,806 23.00 1.54M 1,623,426
2020-10-01 Richards C Marc Officer D Common Stock 0 0.00 23,498
2020-09-27 Hinson Roger Mack Officer D Common Stock 0 0.00 16,279
2020-09-26 Andreano Dominic J Officer A-Award A Common Stock 21,686 0.00 75,394
2020-09-15 Nikolopoulos Nicholas J Officer S-Sale D Common Stock 10,000 19.02 190.2K 71,954
2020-09-15 Andreano Dominic J Officer S-Sale D Common Stock 22,000 18.93 416.4K 53,708
2020-07-31 FARBER STEPHEN D Officer G-Gift D Common Stock 200,000 0.00 78,027
2020-07-12 Weis Shirley A Director D Common Stock 0 0.00 1,007
2020-07-12 Starcher John M. Jr. Director D Common Stock 0 0.00 616
2020-07-12 SANSONE GUY P Director D Common Stock 0 0.00 14,300
2020-07-12 ORDAN MARK S Director / Officer 0 0.00 0
2020-07-12 Nikolopoulos Nicholas Officer F-InKind D Common Stock 53,174 17.65 938.5K 81,954
2020-07-12 McEachin Thomas Director D Common Stock 0 0.00 625
2020-07-12 FARBER STEPHEN D Officer F-InKind D Common Stock 151,581 17.65 2.68M 278,027
2020-07-12 Andreano Dominic J Officer F-InKind D Common Stock 32,413 17.65 572.1K 75,708
2020-06-02 FARBER STEPHEN D Officer A-Award A Common Stock 200,000 0.00 429,608
2020-06-01 Pepia John C Officer F-InKind D Common Stock 329 15.53 5.1K 110,449
2020-06-01 MEDEL ROGER MD Director / Officer F-InKind D Common Stock 14,499 15.53 225.2K 1,704,612
2020-06-01 Andreano Dominic J Officer F-InKind D Common Stock 1,179 15.53 18.3K 108,121
2020-03-01 Pepia John C Officer M-Exempt A Common Stock 7,862 0.00 113,638
2020-03-01 MEDEL ROGER MD Director / Officer F-InKind D Common Stock 43,137 17.09 737.2K 1,719,111
2020-03-01 FARBER STEPHEN D Officer F-InKind D Common Stock 9,134 17.09 156.1K 229,608
2020-03-01 Andreano Dominic J Officer M-Exempt D Restricted Shares Units 9,828 0.00 0
2020-02-13 WALDEMAR, MD CARLO A Director A-Award A Common Stock 4,717 0.00 31,802
2020-02-13 SOSA ENRIQUE Director A-Award A Common Stock 4,717 0.00 37,350
2020-02-13 Rucker Michael A. Director A-Award A Common Stock 4,717 0.00 15,462
2020-02-13 Pepia John C Officer A-Award A Common Stock 18,498 0.00 105,776
2020-02-13 Migoya Carlos A Director A-Award A Common Stock 4,717 0.00 12,062
2020-02-13 MEDEL ROGER MD Director / Officer A-Award A Common Stock 227,525 0.00 1,762,248
2020-02-13 Kadre Manuel Director A-Award A Common Stock 4,717 0.00 124,313
2020-02-13 Goldschmidt, MD Pascal J Director A-Award A Common Stock 4,717 0.00 15,538
2020-02-13 GABOS PAUL G Director A-Award A Common Stock 4,717 0.00 24,313
2020-02-13 FERNANDEZ MICHAEL Director A-Award A Common Stock 4,717 0.00 355,005
2020-02-13 FARBER STEPHEN D Officer A-Award A Common Stock 88,791 0.00 238,742
2020-02-13 Barker Karey D Director A-Award A Common Stock 4,717 0.00 17,778
2020-02-13 Andreano Dominic J Officer A-Award A Common Stock 49,945 0.00 109,310
2020-02-13 ALVAREZ CESAR L Director A-Award A Common Stock 4,717 0.00 48,403
2019-12-01 Clark David A. Officer F-InKind D Common Stock 10,625 26.12 277.5K 123,032
2019-12-01 Andreano Dominic J Officer F-InKind D Common Stock 2,952 26.12 77.1K 59,365
2019-11-01 Goldschmidt, MD Pascal J Director S-Sale D Common Stock 5,000 22.88 114.4K 10,821
2019-09-03 Goldschmidt, MD Pascal J Director S-Sale D Common Stock 5,000 20.81 104.1K 15,821
2019-09-01 FARBER STEPHEN D Officer F-InKind D Common Stock 19,675 21.08 414.7K 149,951
2019-08-12 FERNANDEZ MICHAEL Director P-Purchase A Common Stock 61,205 21.35 1.31M 350,288
2019-08-09 FERNANDEZ MICHAEL Director P-Purchase A Common Stock 124,553 21.52 2.68M 289,083
2019-08-08 FERNANDEZ MICHAEL Director P-Purchase A Common Stock 64,242 21.68 1.39M 164,530
2019-06-01 Pepia John C Officer A-Award A Common Stock 50,690 0.00 86,758
2019-06-01 MEDEL ROGER MD Director / Officer F-InKind D Common Stock 24,155 24.66 595.7K 1,534,723
2019-06-01 Clark David A. Officer F-InKind D Common Stock 3,307 24.66 81.6K 133,657
2019-06-01 CALABRO JOSEPH M Officer F-InKind D Common Stock 14,729 24.66 363.2K 414,679
2019-06-01 Andreano Dominic J Officer F-InKind D Common Stock 2,144 24.66 52.9K 62,317
2019-05-16 Rucker Michael A. Director D Common Stock 0 0.00 10,745
2019-05-16 Migoya Carlos A Director D Common Stock 0 0.00 7,345
2019-03-13 Goldschmidt, MD Pascal J Director S-Sale D Common Stock 3,300 30.40 100.3K 20,821
2019-03-07 Andreano Dominic J Officer S-Sale D Common Stock 4,608 30.16 139.0K 64,461
2019-03-01 MEDEL ROGER MD Director / Officer F-InKind D Common Stock 19,331 32.91 636.2K 1,558,878
2019-03-01 Clark David A. Officer S-Sale D Common Stock 6,452 32.90 212.3K 136,964
2019-03-01 CALABRO JOSEPH M Officer S-Sale D Common Stock 12,130 32.91 399.2K 429,408
2019-02-28 WALDEMAR, MD CARLO A Director M-Exempt A Stock Options (Right to Buy) 17,584 18.91 332.5K 0
2019-02-27 SOSA ENRIQUE Director M-Exempt A Stock Options (Right to Buy) 17,584 18.91 332.5K 0
2019-02-20 Andreano Dominic J Officer S-Sale D Common Stock 1,289 36.22 46.7K 69,069
2019-02-12 WALDEMAR, MD CARLO A Director A-Award A Common Stock 3,699 0.00 19,596
2019-02-12 SOSA ENRIQUE Director A-Award A Common Stock 3,699 0.00 25,005

Executive team

Top executives
EBIT / Employee
61.3K
Shares Outstanding
83.07M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2025 Mark S. Ordan Chief Executive Officer 970.0K 2.00M 8.46M 2.70M 14.2K 14.14M 59.80%
2 2025 Don Gregory Neeb Executive Vice President, Chief Investment & Strategy Officer 229.2K 1.00M 3.57M 518.7K 125.00 5.32M 67.13%
3 2025 Mary Ann E. Moore Executive Vice President, General Counsel, Chief Administrative Officer and Secretary 500.0K 1.39M 1.13M 14.2K 3.03M 45.92%
4 2025 James D. Swift, M.D. Former Chief Executive Officer 54.2K 730.7K 69.0K 1.92M 2.78M 26.32%
5 2025 Kasandra H. Rossi Executive Vice President, Chief Financial Officer & Treasurer 437.5K 598.3K 810.0K 14.3K 1.86M 32.16%
6 2024 James D. Swift, M.D. Former Chief Executive Officer 650.0K 1.18M 1.46M 8.4K 3.30M 35.75%
7 2024 C. Marc Richards Former Executive Vice President, Chief Financial Officer 375.0K 1.07M 375.3K 955.5K 2.78M 38.65%
8 2024 Mary Ann E. Moore Executive Vice President, General Counsel, Chief Administrative Officer and Secretary 485.4K 767.5K 1.13M 10.6K 2.39M 32.13%
9 2024 Curtis B. Pickert, M.D. Former Executive Vice President, Chief Physician Executive 500.0K 767.5K 868.6K 10.5K 2.15M 35.75%
10 2024 Lee A. Wood Former Executive Vice President, National and Market Operations 220.6K 575.7K 163.3K 772.7K 1.73M 33.23%
11 2024 Kasandra H. Rossi Executive Vice President, Chief Financial Officer & Treasurer 368.8K 391.7K 573.8K 10.6K 1.34M 29.13%
12 2023 James D. Swift, M.D. Chief Executive Officer 650.0K 390.0K 1.03M 162.5K 10.3K 2.24M 45.80%
13 2023 James D. Swift, M.D. Former Chief Executive Officer 650.0K 390.0K 1.03M 162.5K 10.3K 2.24M 45.80%
14 2023 Curtis B. Pickert, M.D. Executive Vice President, Chief Operating Officer 500.0K 240.0K 1.03M 100.0K 10.2K 1.88M 54.70%
15 2023 Curtis B. Pickert, M.D. Former Executive Vice President, Chief Physician Executive 500.0K 240.0K 1.03M 100.0K 10.2K 1.88M 54.70%
16 2023 Mary Ann E. Moore Executive Vice President, General Counsel, Chief Administrative Officer and Secretary 475.0K 228.0K 1.03M 95.0K 10.3K 1.83M 55.95%
17 2023 Mary Ann E. Moore Executive Vice President, General Counsel and Secretary 475.0K 228.0K 1.03M 95.0K 10.3K 1.83M 55.95%
18 2023 C. Marc Richards Former Executive Vice President, Chief Financial Officer 500.0K 240.0K 933.4K 100.0K 10.3K 1.78M 52.33%
19 2023 C. Marc Richards Executive Vice President and Chief Financial Officer 500.0K 240.0K 933.4K 100.0K 10.3K 1.78M 52.33%
20 2023 Lee A. Wood Executive Vice President, National and Market Operations 425.0K 153.0K 740.0K 63.8K 10.3K 1.39M 53.16%
21 2023 Lee A. Wood Former Executive Vice President, National and Market Operations 425.0K 153.0K 740.0K 63.8K 10.3K 1.39M 53.16%
22 2022 Mark S. Ordan Executive Chair (Former Chief Executive Officer) 1.00M 3.50M 155.7K 4.66M 75.18%
23 2022 Dominic J. Andreano Former Executive Vice President, General Counsel and Secretary 395.8K 1.35M 394.5K 81.1K 2.22M 60.77%
24 2022 C. Marc Richards Executive Vice President and Chief Financial Officer 500.0K 1.40M 9.6K 1.91M 73.31%
25 2022 C. Marc Richards Former Executive Vice President, Chief Financial Officer 500.0K 1.40M 9.6K 1.91M 73.31%
26 2022 James D. Swift, M.D. Former Chief Executive Officer 450.0K 825.0K 90.0K 9.5K 1.37M 60.02%
27 2022 James D. Swift, M.D. Chief Executive Officer (Former Executive Vice President and Chief Operating Officer) 450.0K 825.0K 90.0K 9.5K 1.37M 60.02%
28 2022 James D. Swift, M.D. Chief Executive Officer 450.0K 825.0K 90.0K 9.5K 1.37M 60.02%
29 2022 Mary Ann E. Moore Executive Vice President, General Counsel, Chief Administrative Officer and Secretary 437.5K 750.0K 95.0K 9.5K 1.29M 58.05%
30 2022 Mary Ann E. Moore Executive Vice President, General Counsel and Secretary 437.5K 750.0K 95.0K 9.5K 1.29M 58.05%
31 2022 Mary Ann E. Moore Executive Vice President, General Counsel and Secretary (Former Executive Vice President, Chief Enterprise Risk and Legal Operations Officer) 437.5K 750.0K 95.0K 9.5K 1.29M 58.05%
32 2021 Mark S. Ordan Chief Executive Officer 1.00M 3.50M 2.34M 8.9K 6.85M 51.10%
33 2021 Mark S. Ordan Executive Chair (Former Chief Executive Officer) 1.00M 3.50M 2.34M 8.9K 6.85M 51.10%
34 2021 Roger Mack Hinson, M.D. President, Pediatrix and Obstetrix Medical Group 550.0K 1.50M 858.0K 8.9K 2.92M 51.42%
35 2021 C. Marc Richards Executive Vice President and Chief Financial Officer 500.0K 1.40M 780.0K 8.9K 2.69M 52.07%
36 2021 Dominic J. Andreano Former Executive Vice President, General Counsel and Secretary 500.0K 1.35M 780.0K 8.9K 2.64M 51.16%
37 2021 Dominic J. Andreano Executive Vice President, General Counsel and Secretary 500.0K 1.35M 780.0K 8.9K 2.64M 51.16%
38 2021 John C. Pepia Senior Vice President and Chief Accounting Officer (former Principal Accounting Officer) 425.0K 500.0K 497.3K 8.9K 1.43M 34.94%
39 2021 Mary Ann E. Moore Executive Vice President, General Counsel and Secretary (Former Executive Vice President, Chief Enterprise Risk and Legal Operations Officer) 364.9K 200.0K 286.0K 8.9K 859.9K 23.26%
40 2021 Mary Ann E. Moore Executive Vice President, General Counsel and Secretary 364.9K 200.0K 286.0K 8.9K 859.9K 23.26%
41 2021 Mary Ann E. Moore Executive Vice President, Enterprise Risk and Legal Operations Officer 364.9K 200.0K 286.0K 8.9K 859.9K 23.26%
42 2020 Roger J. Medel, M.D. Former Chief Executive Officer 1.00 6.15M 780.8K 666.4K 7.60M 80.95%
43 2020 Stephen D. Farber Former Executive Vice President and Chief Financial Officer 345.8K 5.69M 413.3K 590.1K 7.04M 80.84%
44 2020 Mark S. Ordan Executive Chair (Former Chief Executive Officer) 471.0K 2.00M 3.00M 709.0K 258.7K 6.44M 77.66%
45 2020 Mark S. Ordan Chief Executive Officer 471.0K 2.00M 3.00M 709.0K 258.7K 6.44M 77.66%
46 2020 Dominic J. Andreano Former Executive Vice President, General Counsel and Secretary 431.3K 1.70M 470.9K 500.0K 274.8K 3.38M 64.29%
47 2020 Dominic J. Andreano Executive Vice President, General Counsel and Secretary 431.3K 1.70M 470.9K 500.0K 274.8K 3.38M 64.29%
48 2020 Roger Mack Hinson, M.D. President, Pediatrix and Obstetrix Medical Group 432.8K 965.0K 706.6K 550.0K 258.8K 2.91M 57.38%
49 2020 Nicholas J. Nikolopoulos Former Executive Vice President and Chief Strategy & Growth Officer 431.3K 1.30M 500.0K 349.2K 2.58M 50.38%
50 2020 C. Marc Richards Executive Vice President and Chief Financial Officer 157.2K 700.0K 944.1K 157.1K 8.6K 1.97M 83.58%
51 2020 John C. Pepia Senior Vice President and Chief Accounting Officer (former Principal Accounting Officer) 371.9K 500.0K 318.8K 108.8K 1.30M 38.48%
52 2020 John C. Pepia Senior Vice President and Chief Accounting Officer 371.9K 500.0K 318.8K 108.8K 1.30M 38.48%
53 2019 Roger J. Medel, M.D. Former Chief Executive Officer 500.0K 6.15M 1.13M 291.2K 8.07M 76.24%
54 2019 Joseph M. Calabro Former President 300.0K 3.75M 223.2K 538.9K 4.81M 77.93%
55 2019 Stephen D. Farber Executive Vice President and Chief Financial Officer 550.0K 2.40M 412.5K 36.6K 3.40M 70.61%
56 2019 Stephen D. Farber Former Executive Vice President and Chief Financial Officer 550.0K 2.40M 412.5K 36.6K 3.40M 70.61%
57 2019 David A. Clark Former Chief Operating Officer 525.0K 1.95M 393.8K 8.6K 2.88M 67.77%
58 2019 John C. Pepia Senior Vice President and Chief Accounting Officer 406.2K 1.50M 159.4K 8.6K 2.07M 72.32%
59 2019 John C. Pepia Senior Vice President and Chief Accounting Officer (former Principal Accounting Officer) 406.2K 1.50M 159.4K 8.6K 2.07M 72.32%
60 2019 Dominic J. Andreano Executive Vice President, General Counsel and Secretary 475.0K 1.05M 356.3K 8.6K 1.89M 55.56%
61 2018 Roger J. Medel, M.D. Former Chief Executive Officer 1.00M 8.00M 669.0K 269.0K 9.94M 80.50%
62 2018 Roger J. Medel, M.D. Chief Executive Officer 1.00M 8.00M 669.0K 269.0K 9.94M 80.50%
63 2018 Joseph M. Calabro Former President 600.0K 5.00M 267.6K 155.8K 6.02M 83.01%
64 2018 Joseph M. Calabro President 600.0K 5.00M 267.6K 155.8K 6.02M 83.01%
65 2018 Stephen D. Farber Former Executive Vice President and Chief Financial Officer 192.9K 4.76M 191.4K 607.4K 5.75M 82.75%
66 2018 Stephen D. Farber Executive Vice President and Chief Financial Officer 192.9K 4.76M 191.4K 607.4K 5.75M 82.75%
67 2018 David A. Clark Former Chief Operating Officer 483.3K 3.22M 234.2K 11.3K 3.95M 81.55%
68 2018 David A. Clark Chief Operating Officer 483.3K 3.22M 234.2K 11.3K 3.95M 81.55%
69 2018 Vivian Lopez-Blanco. Former Chief Financial Officer and Treasurer 475.0K 2.00M 211.9K 11.3K 2.70M 74.13%
70 2018 Dominic J. Andreano Senior Vice President, General Counsel and Secretary 433.3K 1.35M 211.9K 11.3K 2.01M 67.33%
71 2018 Dominic J. Andreano Executive Vice President, General Counsel and Secretary 433.3K 1.35M 211.9K 11.3K 2.01M 67.33%
72 2017 Roger J. Medel, M.D. Former Chief Executive Officer 1.00M 6.15M 215.5K 7.37M 83.50%
73 2017 Roger J. Medel, M.D. Chief Executive Officer 1.00M 6.15M 215.5K 7.37M 83.50%
74 2017 Joseph M. Calabro Former President 600.0K 3.75M 90.8K 4.44M 84.44%
75 2017 Joseph M. Calabro President 600.0K 3.75M 90.8K 4.44M 84.44%
76 2017 Joseph M. Calabro President and Chief Operating Officer 600.0K 3.75M 90.8K 4.44M 84.44%
77 2017 David A. Clark Former Chief Operating Officer 450.0K 1.60M 337.5K 18.3K 2.41M 66.51%
78 2017 David A. Clark President, MEDNAX National Medical Group 450.0K 1.60M 337.5K 18.3K 2.41M 66.51%
79 2017 David A. Clark Chief Operating Officer 450.0K 1.60M 337.5K 18.3K 2.41M 66.51%
80 2017 Vivian Lopez-Blanco. Chief Financial Officer and Treasurer 475.0K 1.30M 11.1K 1.79M 72.79%
81 2017 Vivian Lopez-Blanco. Former Chief Financial Officer and Treasurer 475.0K 1.30M 11.1K 1.79M 72.79%
82 2017 Dominic J. Andreano Senior Vice President, General Counsel and Secretary 350.0K 1.00M 196.9K 11.1K 1.56M 64.19%
83 2017 Dominic J. Andreano Executive Vice President, General Counsel and Secretary 350.0K 1.00M 196.9K 11.1K 1.56M 64.19%
84 2016 Roger J. Medel, M.D. Chief Executive Officer 1.00M 6.15M 444.0K 230.8K 7.82M 78.60%
85 2016 Joseph M. Calabro President 600.0K 3.75M 177.6K 142.7K 4.67M 80.29%
86 2016 Joseph M. Calabro President and Chief Operating Officer 600.0K 3.75M 177.6K 142.7K 4.67M 80.29%
87 2016 Karl B. Wagner President, Eastern Division 500.0K 1.63M 148.0K 13.0K 2.29M 71.09%
88 2016 Vivian Lopez-Blanco. Chief Financial Officer and Treasurer 454.2K 1.30M 140.6K 13.3K 1.91M 68.13%
89 2016 Vivian Lopez-Blanco Chief Financial Officer and Treasurer 454.2K 1.30M 140.6K 13.3K 1.91M 68.13%
90 2016 Vivian Lopez-Blanco. Former Chief Financial Officer and Treasurer 454.2K 1.30M 140.6K 13.3K 1.91M 68.13%
91 2016 Michael D. Stanley, M.D. President, Clinical Services Division 450.0K 825.1K 99.9K 15.4K 1.39M 59.34%
92 2015 Roger J. Medel, M.D. Chief Executive Officer 1.00M 6.15M 1.69M 172.9K 9.01M 68.25%
93 2015 Joseph M. Calabro President and Chief Operating Officer 600.0K 3.75M 675.0K 60.5K 5.09M 73.74%
94 2015 Karl B. Wagner President, Eastern Division 500.0K 1.63M 562.5K 12.7K 2.70M 60.18%
95 2015 Vivian Lopez-Blanco Chief Financial Officer and Treasurer 425.0K 1.15M 478.1K 12.8K 2.07M 55.67%
96 2015 Vivian Lopez-Blanco. Chief Financial Officer and Treasurer 425.0K 1.15M 478.1K 12.8K 2.07M 55.67%
97 2015 Michael D. Stanley, M.D. President, Clinical Services Division 450.0K 825.0K 379.7K 12.5K 1.67M 49.49%
98 2015 Michael D. Stanley, M.D President, Clinical Services Division 450.0K 825.0K 379.7K 12.5K 1.67M 49.49%
99 2014 Roger J. Medel, M.D. Chief Executive Officer 1.00M 6.15M 1.92M 156.9K 9.22M 66.68%
100 2014 Joseph M. Calabro President and Chief Operating Officer 600.0K 3.75M 766.6K 79.5K 5.20M 72.17%
101 2014 Karl B. Wagner President, Eastern Division 500.0K 1.40M 575.0K 12.6K 2.49M 56.28%
102 2014 Karl B. Wagner President, American Anesthesiology 500.0K 1.40M 575.0K 12.6K 2.49M 56.28%
103 2014 Vivian Lopez-Blanco Chief Financial Officer and Treasurer 414.6K 1.15M 543.0K 12.9K 2.12M 54.23%
104 2014 Vivian Lopez-Blanco. Chief Financial Officer and Treasurer 414.6K 1.15M 543.0K 12.9K 2.12M 54.23%
105 2014 Michael D. Stanley, M.D President, Clinical Services Division 450.0K 825.0K 388.1K 18.2K 1.68M 49.07%
106 2014 Michael D. Stanley, M.D President, Pediatrix Medical Group 450.0K 825.0K 388.1K 18.2K 1.68M 49.07%
107 2014 Michael D. Stanley, M.D. President, Pediatrix Medical Group 450.0K 825.0K 388.1K 18.2K 1.68M 49.07%
108 2014 Michael D. Stanley, M.D. President, Clinical Services Division 450.0K 825.0K 388.1K 18.2K 1.68M 49.07%
109 2013 Roger J. Medel, M.D. Chief Executive Officer 1.00M 6.15M 1.50M 196.8K 8.85M 69.52%
110 2013 Joseph M. Calabro President and Chief Operating Officer 600.0K 3.75M 600.0K 62.1K 5.01M 74.82%
111 2013 Chief Executive Officer 600.0K 3.75M 600.0K 62.1K 5.01M 74.82%
112 2013 Karl B. Wagner President, Eastern Division 500.0K 1.62M 500.0K 13.1K 2.64M 61.60%
113 2013 Vivian Lopez-Blanco. Chief Financial Officer and Treasurer Joseph M. Calabro President and Chief Operating Officer Karl B. Wagner President, American Anesthesiology 500.0K 1.62M 500.0K 13.1K 2.64M 61.60%
114 2013 Karl B. Wagner President, American Anesthesiology 500.0K 1.62M 500.0K 13.1K 2.64M 61.60%
115 2013 Vivian Lopez-Blanco. Chief Financial Officer and Treasurer 400.0K 1,000.0K 400.0K 13.3K 1.81M 55.15%
116 2013 Vivian Lopez-Blanco Chief Financial Officer and Treasurer 400.0K 1,000.0K 400.0K 13.3K 1.81M 55.15%
117 2013 Michael D. Stanley, M.D. President, Pediatrix Medical Group 450.0K 812.5K 337.5K 13.1K 1.61M 50.37%
118 2013 Michael D. Stanley, M.D President, Clinical Services Division 450.0K 812.5K 337.5K 13.1K 1.61M 50.37%
119 2013 Michael D. Stanley, M.D President, Pediatrix Medical Group 450.0K 812.5K 337.5K 13.1K 1.61M 50.37%
120 2012 Roger J. Medel, M.D. Chief Executive Officer 1.00M 6.15M 1.69M 160.0K 9.00M 68.33%
121 2012 Roger J. Medel, M.D. Chief Executive Officer 1.00M 6.15M 1.69M 160.0K 9.00M 68.33%
122 2012 Joseph M. Calabro President and Chief Operating Officer 600.0K 3.75M 676.0K 131.1K 5.16M 72.72%
123 2012 Chief Executive Officer 600.0K 3.75M 676.0K 131.1K 5.16M 72.72%
124 2012 Vivian Lopez-Blanco. Chief Financial Officer and Treasurer Joseph M. Calabro President and Chief Operating Officer Karl B. Wagner President, American Anesthesiology 500.0K 1.63M 563.3K 13.0K 2.70M 60.16%
125 2012 Karl B. Wagner President, American Anesthesiology 500.0K 1.63M 563.3K 13.0K 2.70M 60.16%
126 2012 Vivian Lopez-Blanco Chief Financial Officer and Treasurer 375.0K 750.0K 422.5K 13.4K 1.56M 48.05%
127 2012 Michael D. Stanley, M.D. President, Pediatrix Medical Group 446.5K 712.5K 380.2K 16.0K 1.56M 45.81%
128 2012 Michael D. Stanley, M.D President, Pediatrix Medical Group 446.5K 712.5K 380.2K 16.0K 1.56M 45.81%
129 2012 Michael D. Stanley, M.D President, Pediatrix Division 446.5K 712.5K 380.2K 16.0K 1.56M 45.81%
130 2011 Roger J. Medel, M.D. Chief Executive Officer 969.9K 9.70M 1.46M 308.0K 12.43M 78.01%
131 2011 Roger J. Medel, M.D. Chief Executive Officer 969.9K 9.70M 1.46M 308.0K 12.43M 78.02%
132 2011 Chief Executive Officer 600.0K 2.45M 600.0K 139.9K 3.79M 64.65%
133 2011 Joseph M. Calabro President and Chief Operating Officer 600.0K 2.45M 600.0K 139.9K 3.79M 64.65%
134 2011 Karl B. Wagner President, American Anesthesiology, Inc. 500.0K 1.62M 500.0K 35.5K 2.66M 61.08%
135 2011 Vivian Lopez-Blanco. Chief Financial Officer and Treasurer Joseph M. Calabro President and Chief Operating Officer Karl B. Wagner President, American Anesthesiology 500.0K 1.62M 500.0K 35.5K 2.66M 61.08%
136 2011 Thomas W. Hawkins Senior Vice President, General Counsel and Secretary 425.0K 1.22M 425.0K 16.1K 2.09M 58.48%
137 2011 Vivian Lopez-Blanco Chief Financial Officer and Treasurer 325.0K 575.0K 325.0K 17.2K 1.24M 46.29%
138 2010 Roger J. Medel, M.D. Chief Executive Officer 950.0K 4.10M 1.14M 336.5K 6.53M 62.82%
139 2010 Joseph M. Calabro President and Chief Operating Officer 600.0K 2.45M 480.0K 201.2K 3.73M 65.66%
140 2010 Karl B. Wagner President, American Anesthesiology, Inc. 500.0K 1.63M 400.0K 34.5K 2.56M 63.49%
141 2010 Thomas W. Hawkins Senior Vice President, General Counsel and Secretary 425.0K 1.22M 340.0K 399.00 1.99M 61.45%
142 2010 Vivian Lopez-Blanco. Chief Financial Officer and Treasurer Joseph M. Calabro President and Chief Operating Officer Karl B. Wagner President, American Anesthesiology 300.0K 465.0K 180.0K 15.3K 960.3K 48.42%
143 2010 Vivian Lopez-Blanco Chief Financial Officer and Treasurer 300.0K 465.0K 180.0K 15.3K 960.3K 48.42%
144 2009 Roger J. Medel, M.D. Chief Executive Officer 950.0K 4.10M 2.85M 223.0K 8.12M 50.47%
145 2009 Joseph M. Calabro President and Chief Operating Officer 600.0K 2.45M 1.20M 67.1K 4.32M 56.75%
146 2009 Karl B. Wagner Chief Financial Officer 500.0K 1.62M 1.00M 23.6K 3.15M 51.61%
147 2009 Karl B. Wagner President, American Anesthesiology, Inc. 500.0K 1.62M 1.00M 23.6K 3.15M 51.61%
148 2009 Thomas W. Hawkins Senior Vice President, General Counsel and Secretary 425.0K 1.22M 850.0K 420.00 2.50M 48.89%
149 2009 Frederick V. Miller, M.D. 425.0K 619.2K 478.1K 10.2K 1.53M 40.40%
150 2008 Roger J. Medel, M.D. Chief Executive Officer 887.5K 138.3K 7.80M 1.77M 336.7K 146.5K 11.07M 86.37%
151 2008 Roger J. Medel, M.D Chief Executive Officer 887.5K 138.3K 1.94M 1.16M 336.7K 146.5K 4.61M 67.25%
152 2008 Joseph M. Calabro President and Chief Operating Officer 564.6K 68.2K 1.35M 1.06M 141.8K 9.6K 3.19M 75.42%
153 2008 Karl B. Wagner President, American Anesthesiology, Inc. 470.8K 56.9K 898.4K 706.0K 118.2K 9.6K 2.26M 71.00%
154 2008 Karl B. Wagner Chief Financial Officer 470.8K 56.9K 898.4K 706.0K 118.2K 9.6K 2.26M 71.00%
155 2008 Thomas W. Hawkins Senior Vice President, General Counsel and Secretary 414.6K 48.3K 673.8K 529.5K 100.4K 420.00 1.77M 68.10%
156 2007 Roger J. Medel, M.D. Chief Executive Officer 800.0K 89.6K 1.13M 589.9K 799.2K 83.3K 3.49M 49.28%
157 2007 Roger J. Medel, M.D Chief Executive Officer 800.0K 89.6K 1.13M 589.9K 799.2K 83.3K 3.49M 49.28%
158 2007 Roger J. Medel, M.D. Chief Executive Officer 800.0K 89.6K 934.2K 763.5K 799.2K 83.3K 3.47M 48.93%
159 2007 Joseph M. Calabro President and Chief Operating Officer 515.0K 57.7K 1.40M 572.6K 514.5K 31.5K 3.09M 63.83%
160 2007 Joseph M. Calabro President and Chief Operating Officer 515.0K 57.7K 848.7K 442.4K 514.5K 31.5K 2.41M 53.58%
161 2007 Karl B. Wagner Chief Financial Officer and Treasurer 430.0K 48.2K 636.5K 331.8K 429.6K 9.4K 1.89M 51.36%
162 2007 Karl B. Wagner Chief Financial Officer 430.0K 48.2K 525.5K 429.5K 429.6K 9.4K 1.87M 51.01%
163 2007 Thomas W. Hawkins Senior Vice President, General Counsel and Secretary 400.0K 44.8K 565.7K 294.9K 399.6K 420.00 1.71M 50.47%
164 2007 Thomas W. Hawkins Senior Vice President, General Counsel and Secretary 400.0K 44.8K 467.1K 381.8K 399.6K 420.00 1.69M 50.12%
165 2006 Roger J. Medel, M.D. Chief Executive Officer 800.0K 1.48M 669.0K 945.8K 50.5K 3.94M 54.45%
166 2006 Roger J. Medel, M.D Chief Executive Officer 800.0K 1.48M 669.0K 945.8K 50.5K 3.94M 54.45%
167 2006 Joseph M. Calabro President and Chief Operating Officer 515.0K 1.48M 456.0K 608.9K 9.4K 3.07M 63.05%
168 2006 Joseph M. Calabro President and Chief Operating Officer 515.0K 1.48M 456.0K 608.9K 9.4K 3.07M 63.05%
169 2006 Roger J. Medel, M.D. Chief Executive Officer 800.0K 1.48M 945.8K 50.5K 3.00M 49.31%
170 2006 Karl B. Wagner Chief Financial Officer 430.0K 1.11M 342.0K 508.4K 9.4K 2.40M 60.47%
171 2006 Karl B. Wagner Chief Financial Officer and Treasurer 430.0K 1.11M 342.0K 508.4K 9.4K 2.40M 60.47%
172 2006 Thomas W. Hawkins Senior Vice President, General Counsel and Secretary 400.0K 739.2K 365.5K 472.9K 624.00 1.98M 55.84%
173 2006 Thomas W. Hawkins Senior Vice President, General Counsel and Secretary 400.0K 739.2K 365.5K 472.9K 624.00 1.98M 55.84%
174 2005 Joseph M. Calabro President and Chief Operating Officer 450.0K 477.0K 4.21M 9.0K 5.14M 81.80%
175 2005 Roger J. Medel, M.D. Chief Executive Officer 675.0K 715.5K 2.55M 92.5K 4.03M 63.23%
176 2005 Karl B. Wagner Chief Financial Officer and Treasurer 375.0K 397.5K 3.16M 9.0K 3.94M 80.15%
177 2005 Thomas W. Hawkins Senior Vice President, General Counsel and Secretary 350.0K 371.0K 1.28M 546.00 2.00M 63.86%
178 2004 Roger J. Medel, M.D. Chief Executive Officer 675.0K 523.1K 178.5K 1.38M 0.00%
179 2004 Joseph M. Calabro President and Chief Operating Officer 450.0K 348.8K 8.8K 807.6K 0.00%
180 2004 Karl B. Wagner Chief Financial Officer and Treasurer 375.0K 290.6K 8.8K 674.4K 0.00%
181 2004 Thomas W. Hawkins Senior Vice President, General Counsel and Secretary 350.0K 271.3K 546.00 621.8K 0.00%
182 2003 Roger J. Medel, M.D. Chief Executive Officer 600.0K 600.0K 125.2K 1.33M 0.00%
183 2003 Roger J. Medel, M.D. President and Chief Executive Officer 600.0K 600.0K 81.3K 1.28M 0.00%
184 2003 Joseph M. Calabro President and Chief Operating Officer 350.0K 500.0K 8.7K 858.7K 0.00%
185 2003 Joseph M. Calabro Chief Operating Officer 350.0K 500.0K 8.7K 858.7K 0.00%
186 2003 Karl B. Wagner Chief Financial Officer and Treasurer 300.0K 400.0K 8.6K 708.6K 0.00%
187 2003 Thomas W. Hawkins Senior Vice President, General Counsel and Secretary 192.0K 275.0K 346.00 467.4K 0.00%
188 2003 Kristen Bratberg (Former President and Chief Executive Officer) 142.0K 213.7K 355.6K 0.00%
189 2003 Brian T. Gillon (Former Executive Vice President — Corporate Development, General 128.3K 172.7K 301.0K 0.00%
190 2002 Roger J. Medel, M.D., M.B.A. Chairman of the Board and Chief Executive Officer 600.0K 200.0K 9.8K 809.8K 0.00%
191 2002 Roger J. Medel, M.D. Chief Executive Officer 600.0K 200.0K 8.8K 808.8K 0.00%
192 2002 Roger J. Medel, M.D. President and Chief Executive Officer 600.0K 200.0K 8.8K 808.8K 0.00%
193 2002 Kristen Bratberg (Former President and Chief Executive Officer) 400.0K 400.0K 8.4K 808.4K 0.00%
194 2002 Kristen Bratberg President 400.0K 400.0K 8.4K 808.4K 0.00%
195 2002 Joseph M. Calabro Chief Operating Officer 300.0K 250.0K 8.3K 558.3K 0.00%
196 2002 Joseph M. Calabro President and Chief Operating Officer 300.0K 250.0K 8.3K 558.3K 0.00%
197 2002 Brian T. Gillon (Former Executive Vice President — Corporate Development, General 300.0K 200.0K 8.3K 508.3K 0.00%
198 2002 Brian T. Gillon Executive Vice President — Corporate Development, 300.0K 200.0K 8.3K 508.3K 0.00%
199 2002 Karl B. Wagner Chief Financial Officer and Treasurer 275.0K 225.0K 8.2K 508.2K 0.00%
200 2002 Thomas W. Hawkins Senior Vice President, General Counsel and Secretary
201 2001 Roger J. Medel, M.D., M.B.A. Chairman of the Board and Chief Executive Officer 600.0K 100.0K 6.9K 706.9K 0.00%
202 2001 Roger J. Medel, M.D. President and Chief Executive Officer 600.0K 100.0K 6.9K 706.9K 0.00%
203 2001 Kristen Bratberg President 400.0K 200.0K 5.5K 605.5K 0.00%
204 2001 Kristen Bratberg (Former President and Chief Executive Officer) 400.0K 200.0K 5.5K 605.5K 0.00%
205 2001 Joseph M. Calabro Chief Operating Officer 250.0K 150.0K 5.3K 405.3K 0.00%
206 2001 Brian T. Gillon Executive Vice President — Corporate Development, 250.0K 150.0K 5.3K 405.3K 0.00%
207 2001 Brian T. Gillon (Former Executive Vice President — Corporate Development, General 250.0K 150.0K 5.3K 405.3K 0.00%
208 2001 Karl B. Wagner Chief Financial Officer and Treasurer 225.0K 125.0K 5.3K 355.3K 0.00%
209 2001 Thomas W. Hawkins Senior Vice President, General Counsel and Secretary
210 2000 Roger J. Medel, M.D., M.B.A. Chairman of the Board and Chief Executive Officer 400.0K 100.0K 4.4K 504.4K 0.00%
211 2000 Kristen Bratberg President 300.0K 200.0K 3.8K 503.8K 0.00%
212 2000 Brian T. Gillon Executive Vice President — Corporate Development, 200.0K 125.0K 3.5K 328.5K 0.00%
213 2000 Joseph M. Calabro Chief Operating Officer 193.3K 100.0K 3.6K 296.9K 0.00%
214 2000 Karl B. Wagner Chief Financial Officer and Treasurer 179.2K 75.0K 3.5K 257.7K 0.00%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-04-17 DEFA14A
2026-03-27 DEFA14A
2026-03-27 DEF 14A
2025-03-28 DEFA14A
2025-03-28 DEF 14A
2024-03-28 DEFA14A
2024-03-28 DEF 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-05 8-K
2026-05-05 10-Q
2026-04-17 DEFA14A
2026-03-27 DEFA14A
2026-03-27 DEF 14A
2026-03-27 ARS
2026-03-03 4
2026-03-03 4
2026-02-19 8-K
2026-02-19 10-K

Executive team

NameTitleCompensationGender
Mark S. Ordan Chief Executive Officer & Executive Chairman 6M male
D. Gregory Neeb Executive Vice President and Chief Investment & Strategy Officer 2M male
Mary Ann E. Moore Chief Administrative Officer, Executive Vice President, General Counsel & Secretary 2M female
Kasandra H. Rossi Executive Vice President, Treasurer & Chief Financial Officer 1M female
John C. Pepia Senior Vice President & Chief Accounting Officer 931.2K male
Cheryl VanPatten Senior Vice President & Chief Information Officer female
Nanette Sanders Executive Vice President of National Operations female
Debra McRoberts Senior Vice President of People Services female
Kevin Pitzer President of West Division male
Michael Dwyer Chief Medical Officer of South Central Division
Mike Ashford President of South Central Division male
ESG Rating
B-
MEDICAL - CARE FACILITIES
2014
E (Environmental)
48.0 / 65.7
Company / Sector avg.
S (Social)
45.9 / 69.6
Company / Sector avg.
G (Governance)
68.8 / 68.9
Company / Sector avg.
ESG Total
54.2 / 68.1
Company / Sector avg.
ESG Score History MEDICAL - CARE FACILITIES
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity
Transaction Date Disclosed Representative District Owner Type Amount Link
2019-10-15 2020-04-27 Donna Shalala FL27 -- Sale (Full) $50,001 - $100,000
2018-10-26 2018-10-29 Greg Gianforte MT00 Joint Sale (Full) $50,001 - $100,000
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits